1Gharagozloo F, Margolis M, Tempesta B. Robot-assisted thoracoscopic lobectomy for early-stage lung cancer. Ann Thorac Surg, 2008,85:1880 - 1886.
2Yildizeli B, Dartevelle PG, Fadel E, et al. Results of primary surgery with T4 non-small eell lung cancer during a 25-year period in a single center:the benefit is worth the risk. Ann Thorae Surg,2008, 86 (4) : 1065 - 75 ; discussion 1074 - 1075.
3Scagliotti GV, Pastorino U, Vansteenkiste JF, et al. A phase Ⅲ randomized study of surgery alone or surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung cancer (NSCLC) : Follow-up data of Ch E S T. J Clin Oncol, 2008,26 : ( suppl ) : abstr 7508.
4Bunn PA Jr, Thatcher N. Systemic trestment tor advanced ( stage Ⅲb/Ⅳ) non-small cell lung cancer: more treatment options:more things to consider. Conclusion. Oncologist,2008,13 Suppl 1 : 37 - 46.
5Fessdla F, Pereim JR, von Pawel J, et al. Randomized, multinational, phase Ⅲ studv of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non - small - cell lung cancer: the TAX 326 study group. J Clin Oncol, 2003, 21 : 3016 - 3024.
9Hendry JH, Bentzen SM, Dale RG, et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol, 1996,8 (2) :297 - 307.
10Nguyen NP, Garland L, Welsh J, et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage nonsmall cell lung carcinoma. Cancer Treat Rev, 2008,34 ( 8 ) : 719 - 727.
2Vaporciyan A A, Correa A M, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery : analysis of 2588 patients. J Thorac Cardiovasc Surg, 2004,127 ( 3 ) : 779 - 786.
3Raymond E, Chaney S, Taamma A, et al. Oxalipatin : A review of preclinical studies. Ann Oncol, 1998,9 (7) : 1053 - 1071.
4Monnet I, Brienza S, HugretF, et al. Phase Ⅱ study ofoxaliplatin in poor-prognosis non-small cell lung cancer(NSCLC). ArlTIT. Associa pourle TraitementdesTumeurs Intra Thoraciques. Eur JCancer, 1998, 34(7) :1124 - 1127.
5Dyszkiewicz W, Skrzypczak M. Atrial fibrillation after surgery of the lung:clinical analysis of risk factors. Eur J Cardiothorac Surg, 1998, 13(6) :625 -628.
6Monnet I, de CH, Soulie P, et al. Oxaliplatin plus vinorelbine in advanced no-small-cell lug cancer:final results of a multicenter phase Ⅱ study. Ann Onco,1 2002,13(1) :103 -107.
10Nguyen NP, Garland L, Welsh J, et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non2 small cell lung carcinoma[J]. Cancer Treat Rev, 2008, 34 (8) : 719-727.
